Global Cancer Diagnostics Partnering 2014-2019: Deal trends, players and financials

Global Cancer Diagnostics Partnering 2014-2019: Deal trends, players and financials

The Global Cancer Diagnostics Partnering 2014-2019 report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in cancer diagnostics partnering deals
Disclosed headlines, upfronts, milestones and royalties by stage of development
Cancer diagnostics partnering contract documents
Top cancer diagnostics deals by value

This report provides details of the latest Cancer Diagnostics agreements announced in the life sciences since 2014.

The report takes the reader through a comprehensive review Cancer Diagnostics deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Cancer Diagnostics partnering deals.

The report presents financial deal term values for Cancer Diagnostics deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the Cancer Diagnostics partnering field; both the leading deal values and most active Cancer Diagnostics dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

One of the key highlights of the report is that over 750 online deal records of actual Cancer Diagnostics deals, as disclosed by the deal parties, are included towards the end of the report in a directory format – by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

The initial chapters of this report provide an orientation of Cancer Diagnostics dealmaking. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in Cancer Diagnostics dealmaking since 2014, including details of headline, upfront, milestone and royalty terms.

Chapter 3 provides a review of the leading Cancer Diagnostics deals since 2014. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in Cancer Diagnostics dealmaking with a brief summary followed by a comprehensive listing of Cancer Diagnostics deals announded by that company, as well as contract documents, where available.

Chapter 5 provides a comprehensive and detailed review of Cancer Diagnostics partnering deals signed and announced since Jan 2014, where a contract document is available in the public domain. Each deal title links via Weblink to an online version of the deal record and contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive and detailed review of Cancer Diagnostics partnering deals signed and announced since Jan 2014. The chapter is organized by specific Cancer Diagnostics technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

A comprehensive series of appendices is provided organized by Cancer Diagnostics partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Cancer Diagnostics partnering and dealmaking since 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Cancer Diagnostics technologies and products.

Key benefits

Global Cancer Diagnostics Partnering 2014-2019: Deal trends, players, financials and forecasts provides the reader with the following key benefits:

In-depth understanding of Cancer Diagnostics deal trends since 2014
Access to headline, upfront, milestone and royalty data
Analysis of the structure of Cancer Diagnostics agreements with numerous real life case studies
Detailed access to actual Cancer Diagnostics contracts entered into by leading biopharma companies
Identify most active Cancer Diagnostics dealmakers since 2014
Insight into terms included in a Cancer Diagnostics partnering agreement, with real world examples
Understand the key deal terms companies have agreed in previous deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

Global Cancer Diagnostics Partnering 2014-2019: Deal trends, players, financials and forecasts is intended to provide the reader with an in-depth understanding and access to Cancer Diagnostics trends and structure of deals entered into by leading companies worldwide.

Cancer Diagnostics Partnering Terms and Agreements includes:

Trends in Cancer Diagnostics dealmaking in the biopharma industry since 2014
Analysis of Cancer Diagnostics deal structure
Access to headline, upfront, milestone and royalty data
Case studies of real-life Cancer Diagnostics deals
Access to Cancer Diagnostics contract documents
Leading Cancer Diagnostics deals by value since 2014
Most active Cancer Diagnostics dealmakers since 2014

In Global Cancer Diagnostics Partnering 2014-2019: Deal trends, players, financials and forecasts, the available deals are listed by:

Company A-Z
Headline value
Stage of development at signing
Deal component type
Specific therapy target
Technology type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Cancer Diagnostics Partnering 2014-2019: Deal trends, players, financials and forecasts report provides comprehensive access to available deals and contract documents for over 650 Cancer Diagnostics deals.

Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?
What is actually granted by the agreement to the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How aresalesand payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes to be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement law?


  • Executive Summary
  • Introduction
  • Trends in Cancer Diagnostics dealmaking
    • Introduction
    • Cancer Diagnostics partnering over the years
    • Most active Cancer Diagnostics dealmakers
    • Cancer Diagnostics partnering by deal type
    • Cancer Diagnostics partnering by therapy area
    • Deal terms for Cancer Diagnostics partnering
      • Cancer Diagnostics partnering headline values
        • Table Cancer Diagnostics deals with a headline value
      • Cancer Diagnostics deal upfront payments
        • Table Cancer Diagnostics deals with an upfront value
      • Cancer Diagnostics deal milestone payments
        • Table Cancer Diagnostics deals with a milestone value
      • Cancer Diagnostics royalty rates
        • Table Cancer Diagnostics deals with a royalty rate value
  • Leading Cancer Diagnostics deals
    • Introduction
    • Top Cancer Diagnostics deals by value
      • Table Top Cancer Diagnostics deals by value since 2014
  • Most active Cancer Diagnostics dealmakers
    • Introduction
    • Most active Cancer Diagnostics dealmakers
    • Most active Cancer Diagnostics partnering company profiles
      • National Cancer Institute
      • MDxHealth
      • Illumina
      • Foundation Medicine
      • AstraZeneca
      • MD Anderson Cancer Center
      • Memorial Sloan Kettering Cancer Center
      • Myriad Genetics
      • Biocept
      • Qiagen
      • Cancer Genetics
      • Thermo Fisher Scientific
      • TrovaGene
      • Agendia
      • Biodesix
      • Roche
      • Vigilant Biosciences
      • ImaginAb
      • MEDIAN Technologies
      • National Institutes of Health
      • Personal Genome Diagnostics
      • Quest Diagnostics
      • Rosetta Genomics
      • Telix Pharmaceuticals
      • Ventana Medical Systems
  • Cancer Diagnostics contracts dealmaking directory
    • Introduction
    • Cancer Diagnostics contracts dealmaking directory
  • Cancer Diagnostics dealmaking by technology type
    • Diagnostics
      • Companion
      • Imaging
      • CT
      • Endoscope
      • MRI
      • Molecular and nuclear
      • Ultrasound
      • X-ray
      • In vitro diagnostics
      • Molecular diagnostics
      • Prognostics
      • Theranostics
  • Partnering resource center
    • Online partnering
    • Partnering events
    • Further reading on dealmaking
  • Appendices
    • Cancer Diagnostics deals by company A-Z
      • 14M Genomics
      • 1717 Life Science Ventures
      • 20/20 GeneSystems
      • 3D Signatures
      • 3PrimeDx
      • Abbott Laboratories
      • Abbvie
      • Abcodia
      • Abramson Cancer Center
      • AB Analitica
      • AccuGenomics
      • Accuray
      • Accu Reference Medical Laboratory
      • AceCGT Life Science
      • Acoustic MedSystems
      • ACT Genomics
      • Adaptiiv
      • Adaptive Biotechnologies
      • ADC Therapeutics
      • Admera Health
      • Advanced Accelerator Applications
      • Advanced Cell Diagnostics
      • Advanced Cooling Therapy
      • Advanced Nuclear Medicine Ingredients
      • Aelan Cell Technologies
      • Aetna
      • Agena Bioscience
      • Agendia
      • Agilent Technologies
      • Agios Pharmaceuticals
      • AG Mednet
      • Albert Einstein Healthcare Network
      • Alibaba Health
      • Alliance Global FZ
      • Alliance Global Group
      • Almac Diagnostics
      • Almac Group
      • Alpha Imaging
      • Alteris
      • Amarantus BioSciences
      • Ambry Genetics
      • America's Choice Provider Network
      • American Health Imaging
      • American Lung Association
      • Amgen
      • AmoyDx Diagnostics
      • Amoy Diagnostics
      • Amplitech
      • Analogic
      • Angle
      • Angsana Molecular & Diagnostics
      • Anixa Biosciences
      • Anpac Bio-Medical Science
      • Anthem Bluecross
      • Apogenix
      • Appistry
      • Arbor Vita
      • ArcherDX
      • Arc Medical Design
      • Areva Med
      • Arno Therapeutics
      • AroCell
      • Arquer Diagnostics
      • Array Biopharma
      • Arrow Diagnostics
      • ASPiRA Labs
      • Aspira Scientific
      • Astellas Pharma
      • AstraZeneca
      • Asuragen
      • Austrian Institute of Technology
      • Avantis Medical Systems
      • Avant Diagnostics
      • AVEO Oncology
      • Avera Heart Hospital of South Dakota
      • Axela
      • Axella Research
      • Aytu BioScience
      • Bayer
      • Bayer Healthcare
      • Baylor Genetics
      • Beckman Coulter
      • BeiGene
      • Bertech Diagnostics
      • Bertin Pharma
      • Beyondspring Pharmaceuticals
      • BioAffinity Technologies
      • Biocartis
      • Biocept
      • BioChain
      • Biodesix
      • BioGemex
      • Biognosys
      • Biohealth Innovation
      • BioLizard
      • Biological Dynamics
      • BioMarker Strategies
      • BioMark Diagnostics
      • Biomedical Advanced Research and Development Authority
      • BioMerieux
      • BioNano Genomics
      • BioNova Cientifica
      • Biopsy Sciences
      • Biotech-IgG
      • BioTheranostics
      • BioVendor
      • Biovica
      • Bioyong
      • BL&H
      • Black Swan Research Initiative
      • Bliss Biopharmaceutical
      • BloodCenter Of Wisconsin
      • Bluebee
      • BlueCross BlueShield of Tennessee
      • Blueprint Medicines
      • Blue Cross Blue Shield Association
      • Blue Earth Diagnostics
      • Boehringer Ingelheim
      • Bonnie J. Addario Lung Cancer Foundation
      • Boreal Genomics
      • BostonGene
      • Bostwick Laboratories
      • Bpifrance
      • Bracco Imaging
      • Breath Diagnostics
      • Brigham and Women's Hospital
      • Bristol-Myers Squibb
      • Bristol-Myers Squibb Pakistan
      • Broad Institute
      • Bruker
      • Buck Institute for Age Research
      • Burning Rock
      • Butantan Institute
      • C4 Imaging
      • Caliber Imaging & Diagnostics
      • Cambridge Epigenetix
      • CANbridge Life Sciences
      • Cancer Genetics
      • Cancer Prevention and Research Institute of Texas
      • Cancer Research Institute
      • Cancer Research UK
      • Cancer Targeted Technology
      • Capital X-ray
      • Caprion Proteomics
      • Cardinal Health
      • Carestream Health
      • Care GB Plus
      • Caris Life Sciences
      • CarThera
      • Case Western Reserve University
      • Catholic University Leuven
      • CBD Vida
      • CBLPath
      • CDx Diagnostics
      • Celgene
      • Cellgen Diagnostics
      • CellSight Technologies
      • Cell Signaling Technology
      • Celsee
      • Celsion
      • Celsius Therapeutics
      • Celtic Biotech
      • Center for Connected Health
      • Centogene
      • Centre for Imaging Technology Commercialization
      • Centre for Probe Development and Commercialization
      • Centre Leon Berard
      • Cerba HealthCare
      • Ceres
      • Cernostics
      • Champalimaud Foundation
      • Chembio Diagnostics
      • ChemImage
      • Children's Hospital Boston
      • Children's Hospital Los Angeles
      • Children's Hospital of Orange County
      • Christian Doppler Research Association
      • Chugai Pharmaceutical
      • Circulogene
      • Cirrus Dx
      • City of Hope
      • Clarient
      • Clarity Pharmaceuticals
      • Clearbridge Biomedics
      • ClearLight Diagnostics
      • ClearView Diagnostics
      • Cleveland Clinic
      • Cleveland Diagnostics
      • Clevexel Pharma
      • Clinatec
      • Clinical Genomics
      • CloudHealth Genomics
      • Cloud Pharmaceuticals
      • Clovis Oncology
      • Co-Diagnostics
      • Cobalt Healthcare Consultants
      • Cofactor Genomics
      • Cold Spring Harbor
      • Colorado State University
      • Color Genomics
      • Columbia University
      • Columbia University Medical Center
      • Community Medical Center
      • Concile
      • Contextual Genomics
      • Core Diagnostics India
      • Cornell University
      • Corvida Medical
      • COTA
      • Covidien
      • Crown Bioscience
      • Crown Dental + Medical
      • CSIRO
      • CSI Laboratories
      • Cure Brain Cancer Foundation
      • Cure Forward
      • Curium
      • CyberKnife
      • Cyclopharm
      • Cynvenio
      • CytoLumina Technologies
      • D&K Technologies
      • D-Eye
      • Daiichi Sankyo
      • Dako
      • Dana-Farber Cancer Institute
      • Danish Center for Strategic Research into Type 2 Diabetes
      • DaRui Biotech
      • DarwinHealth
      • Debiopharm
      • Decipher Biosciences
      • DeCODE Genetics
      • Dell
      • Dendreon
      • Densitas
      • Device Technologies
      • Devicor Medical Products
      • DiaCarta
      • DiagnoCure
      • Diagnoplex
      • Diagnostica Longwood
      • Diagnostic Oncology Contract Research Organization
      • Dilon Diagnostics
      • DNAmito
      • Domainex
      • Dr Risch
      • Duke-NUS Graduate Medical School Singapore
      • Duke University
      • Duke University Medical Center
      • DxM Diagnostico Molecular
      • DxTerity
      • DySIS Medical
      • Edico Genome
      • Edinburgh Molecular Imaging
      • EDP Biotech
      • Eigen
      • EKF Diagnostics
      • Elekta
      • Eleven Biotherapeutics
      • Eli Lilly
      • Emory University
      • Endotronix
      • Enigma Biomedical
      • Enterome Bioscience
      • Enzo Clinical Labs
      • Epic Sciences
      • Epigenomics
      • Eurobio
      • European Commission
      • European Health Centre Innovation
      • European Infrastructure for Translational Medicine
      • European Organization for Research and Treatment of Cancer
      • Eutropics Pharmaceuticals
      • Event Cardio Group
      • Everything Genetic
      • Exact Imaging
      • Exact Sciences
      • Exosome Diagnostics
      • Exosome Sciences
      • Faron Pharmaceuticals
      • Federal Ministry of Education and Research (BMBF)
      • FedMed
      • Feinstein Institute for Medical Research
      • FetoLumina Technologies
      • Finnish Funding Agency for Technology and Innovation (TEKES)
      • Five Prime Therapeutics
      • Fluxion Biosciences
      • FLX Bio
      • FNApath
      • Focal Healthcare
      • Fondation Cancer
      • Fondatioun Kriibskrank Kanner
      • FORMA Therapeutics
      • Fortified Provider Network
      • Foundation Medicine
      • Fred Hutchinson Cancer Research Center
      • Freenome
      • Fscan
      • Fudan University
      • Fujirebio Diagnostics
      • Fusion Antibodies
      • Galaxy Health Network
      • Gamma Medica
      • Gen-Probe
      • Genclis
      • Genecast
      • GeneCentric Therapeutics
      • GeneInsight
      • GeneNews
      • GenesisCare
      • Genetic Technologies
      • Genmab
      • Genomac Research Institute
      • GenomeDx
      • Genomeon
      • Genome Canada
      • Genomics England
      • Genomic Health
      • Genomic Testing Cooperative
      • Genomoncology
      • Genoptix
      • Georgia Institute of Technology
      • German Cancer Research Center
      • GE Healthcare
      • Gilead Sciences
      • GIMDx
      • GlaxoSmithKline
      • GLG Pharma
      • Glide
      • Global Cancer Diagnostics
      • Global Discovery Biosciences
      • Global Medical Solutions
      • Gloval Specimen Solutions
      • Glycotest
      • GNS Healthcare
      • GNYHA Services
      • Goodwin Biotechnology
      • Gotect Diagnostic
      • Government of Canada
      • Grail
      • Group Vida
      • Grupo Ferrer
      • Guardant Health
      • Guerbet
      • Guided Therapeutics
      • Guided Therapy Systems
      • Hainan Sinotau Pharmaceutical
      • HalioDx
      • Halozyme Therapeutics
      • Harvard Medical School
      • Harvard Pilgrim Health Care
      • HealthMyne
      • HealthTrust
      • Health Diagnostics Laboratory
      • Hebrew University of Jerusalem
      • Helomics
      • Hemogenomics Pharma
      • Henry Ford Health System
      • Highmark Blue Shield
      • Hitachi
      • Hitachi Aloka Medical
      • Hitachi Medical Systems Europe
      • Hoag Memorial Hospital Presbyterian
      • Hologic
      • Horizon 2020
      • Horizon Discovery
      • Hospital Services
      • HTG Molecular Diagnostics
      • Human Longevity
      • Huntsman Cancer Institute
      • Hvidovre Hospital
      • Hybridyne Imaging Technologies
      • IBA Molecular Imaging
      • Ibex Medical Analytics
      • IBIO Institute's PROPEL Center
      • IBL America
      • IBM
      • IBM Watson Health
      • ICAD
      • Icahn School of Medicine at Mount Sinai
      • Idengene
      • Idera Pharmaceuticals
      • Illumina
      • Image Analysis
      • ImaginAb
      • Imaging Associates
      • Imanis Life Sciences
      • Imegen
      • ImmunID Technologies
      • ImmunoCellular Therapeutics
      • ImmunoGen
      • Immunovia
      • Imperial College London
      • IncellDx
      • Incyte
      • Indiana University
      • Indigo Biosciences
      • Indivumed
      • Inform Genomics
      • Inhibrx
      • Inivata
      • Innovate UK
      • Innovative Diagnostic Laboratory
      • Inovio Pharmaceuticals
      • Inserm
      • Inserm Transfert
      • InSightec
      • Insight Genetics
      • Institute for Bioscience and Biotechnology Research
      • Institute of Biophysics
      • Institute of Cancer Research
      • Instituto Diagnostico Varelli
      • Institut Català d'Oncologia
      • Institut Curie
      • Institut Gustave Roussy
      • IntegraGen
      • Integrated Biobank of Luxembourg
      • Integrated Diagnostics
      • Integrated DNA Technologies
      • Intensity Therapeutics
      • Intermountain Healthcare
      • International Myeloma Foundation
      • Interpace Diagnostics
      • Interpace Diagnostics Group
      • Intezyne
      • Invenra
      • InviCRO
      • Invitae
      • InVivoScribe
      • ION Solutions
      • IPMD
      • Ironwood Pharmaceuticals
      • IRX Therapeutics
      • ISIS Innovation
      • Isotope Technologies Garching
      • Istituto Diagnostico Varelli
      • Item
      • ITEM Medical Technologies
      • ITM Isotopen Technologien
      • IVu Imaging
      • Janssen-Cilag
      • Janssen Biotech
      • Janssen Diagnostics
      • Janssen Pharmaceuticals
      • Janssen Pharmaceutica NV
      • Janssen Research & Development
      • Jazz Pharmaceuticals
      • Jiangsu Hengrui Medicine
      • Johnson & Johnson Innovation
      • Johns Hopkins University
      • John Wayne Cancer Institute
      • JTS Health Partners
      • Jubilant DraxImage
      • Juno Therapeutics
      • Kailos Genetics
      • Kaiser Foundation Research Institute
      • Kaiser Permanente
      • Kalgene Pharmaceuticals
      • Karolinska Institute
      • Keck School of Medicine of USC
      • KEW
      • Kite Pharma
      • Kiyatec
      • Knight Cancer Institute
      • Knight Diagnostic Laboratories
      • Konica Minolta
      • KUB Technologies
      • Kura Oncology
      • Lab21
      • Labcyte
      • Laboratory Corporation of America
      • Lantheus Holding
      • Lee Moffitt Cancer Center
      • Lehigh University
      • Leica Biosystems
      • Leicester University
      • LEO Pharma
      • LifeLabs Medical Laboratory Services
      • LifeX Ventures
      • Life Technologies Corporation
      • Lightpoint Medical
      • LineaRx
      • Li Ka Shing Foundation
      • LI Path
      • Loxo Oncology
      • Lucid Diagnostics
      • LumaMed
      • Lumicell
      • Luminex
      • Lunatus
      • Lund University
      • Lung Cancer Alliance
      • MabVax Therapeutics
      • Macquarie University
      • Magnetic Insight
      • Major Health Partners
      • Manhattan Scientifics
      • Massachusetts General Hospital
      • Massachusetts Institute of Technology
      • Massachusetts Life Sciences Center
      • Mauna Kea Technologies
      • Mavig
      • Mayo Clinic
      • MDL Information Systems
      • MDNA Life Sciences
      • MDxHealth
      • MD Anderson Cancer Center
      • MEDIAN Technologies
      • Medical Imaging
      • Medical Prognosis Institute
      • Medical University of Graz
      • Medical University of South Carolina
      • Mediso
      • Medivation
      • MedPac Asia Pacific
      • MedPhoton
      • Medx
      • Med fusion
      • MELA Sciences
      • Memorial Sloan Kettering Cancer Center
      • Menarini
      • Merck and Co
      • Merck KGaA
      • Merck Serono
      • Merck Sharpe & Dohme
      • Merit Medical Systems
      • Merrimack Pharmaceuticals
      • Metabiomics
      • Metafora Biosystems
      • Metamark Genetics
      • MetaStat
      • Mevion Medical Systems
      • MicroConstants
      • Micromedic Technologies
      • Microsoft
      • Milenia Labs
      • Millennium Medical Devices
      • Ministry of Health (Turkey)
      • Minogue Medical
      • Minomic
      • MIODx
      • Miraca Life Sciences
      • Miragen Therapeutics
      • Mirati Therapeutics
      • MiRXES
      • Mitra Biotech
      • Moldionics
      • MolecularMD
      • Molecular Health
      • Molecular Response
      • Monteris Medical
      • Moores Cancer Center
      • Morphotek
      • Mount Sinai Services
      • Movember Foundation
      • MRI Interventions
      • MRM Proteomics
      • MultiPlan
      • Multiple Myeloma Research Foundation
      • Munich Leukemia Laboratory
      • Myeloma Health
      • Myelopro Diagnostics and Research
      • Myriad Genetics
      • My Gene Counsel
      • N-of-One
      • Nanobeak
      • NanoMab Technology
      • Nanopharmacia
      • NanoString Technologies
      • NantBioScience
      • NantHealth
      • NantWorks
      • NASA
      • Natera
      • National Cancer Centre Singapore
      • National Cancer Institute
      • National Cancer Institute of Mexico
      • National Healthcare Services (NHS)
      • National Institutes of Health
      • National Institute for Public Health and the Environment
      • National Institute of Allergy and Infectious Diseases
      • National Institute of Biomedical Imaging and Bioengineering
      • National Institute of Dental and Craniofacial Research (NIDCR)
      • National Physical Laboratory
      • National Science Foundation
      • National Taiwan University Hospital
      • Natural Sciences and Engineering Research Council of Canada
      • Navidea Biopharmaceuticals
      • Nemucore Medical Innovations
      • Neogenomics
      • NEO New Oncology
      • NetScientific
      • Newmars Group
      • New Jersey Urology
      • Nihon Medi-Physics
      • Ninepoint Medical
      • NM Genomix
      • Norgen Biotek
      • Norgine
      • Norsk medisinsk syklotronsenter
      • Northeastern University
      • Northwestern University
      • North Shore-LIJ Cancer Institute
      • Notable Labs
      • Novartis
      • NovellusDx
      • Novigenix
      • Novogene
      • Nuclea Biotechnologies
      • Nucleix
      • NueHealth
      • NuView Life Sciences
      • OmniSeq
      • Oncgnostics
      • Oncimmune
      • Oncimmune Ltd
      • OncoCyte
      • OncoDNA
      • OncoGenesis
      • Oncology Venture
      • OncoNano Medicine
      • OncoTracker
      • OncoVision
      • Ono Pharmaceutical
      • Ontario Cancer Biomarker Network
      • Ontario Institute for Cancer Research
      • OPKO Health
      • Oregon Health Sciences University
      • Orot+
      • Oslo University Hospital
      • Otsuka
      • OvaGene Oncology
      • Ovarian Cancer Institute
      • Owlstone Medical
      • Oxford BioTherapeutics
      • P-cure
      • Panacea Pharmaceuticals
      • PapGene
      • Paradigm
      • Paris Descartes University
      • PathAI
      • PathGroup
      • Pathway Diagnostics
      • Patient-Centered Outcomes Research Institute (PCORI),
      • PAVmed
      • Pax Neuroscience
      • Pentax
      • PentixaPharm
      • Personalis
      • PersonalizeDx
      • Personalized Medicine Initiative (PMI)
      • Personal Genome Diagnostics
      • Perthera
      • Pfizer
      • Phase Holographic Imaging
      • Philips
      • Philips Healthcare
      • Phi Life Sciences
      • Phoenix Molecular Designs
      • Physician's Choice Laboratory Services
      • PierianDx
      • Pierre Fabre
      • Pippa Mann
      • Planet Innovation
      • Poitiers University
      • Positive Bioscience
      • Precipio Diagnostics
      • Predicine
      • PrediLife
      • Premas Life Sciences
      • PREMIA Holdings
      • Premier Inc
      • Preora Diagnostics
      • Prescient Medical
      • Prime Healthcare Services
      • Prime Health Services
      • Profound Medical
      • Progenetics
      • Progenics Pharmaceuticals
      • ProNova
      • Propper Manufacturing
      • Prostate Cancer Foundation (PCF)
      • Protagen
      • Protea Biosciences
      • Providence Saint John's Health Center
      • Puma Biotechnology
      • Pure MHC
      • QED Therapeutics
      • Qiagen
      • Qualigen
      • Quanterix
      • Queensland University of Technology
      • Queens University Belfast
      • Quest Diagnostics
      • QuiO Technologies
      • R-Biopharm
      • Radboud University Nijmegen Medical Centre
      • Radiomedix
      • Raiing Medical
      • Rainbow Genomics
      • RAW
      • RaySearch Laboratories
      • RedPath Integrated Pathology
      • Renji Hospital
      • ResearchDx
      • Research Center for Molecular Medicine of the Austrian Academy of Sciences
      • Resolution Bioscience
      • Response Genetics
      • RiboMed
      • Riverside Research
      • Robert H. Lurie Comprehensive Cancer Center
      • Roche
      • Rosetta Genomics
      • Roswell Park Cancer Institute
      • ROTOP Pharmaka
      • Royal Marsden Hospital
      • Royal Philips Electronics
      • Rutgers University
      • Sanofi
      • Sarah Cannon Research Institute
      • Sayre Therapeutics
      • SBRI Healthcare
      • Scancell
      • SciBase
      • Scienion
      • Scintomics
      • Seattle Children's Hospital
      • Seattle Childrens Research Institute
      • Seattle Genetics
      • Sebia
      • Sectra
      • Seegene
      • Seibersdorf Laboratories
      • Selexis
      • Sengenics
      • SEngine Precision Medicine
      • Sensus Healthcare
      • Sequenom
      • Sequenta
      • Seracare Life Sciences
      • Shanghai Fosun Long March Medical Science
      • Shanghai Pharmaceutical
      • Sheba Medical Center
      • Shuwen Biotech
      • Siemens
      • Signal Genetics
      • Signet Medical Solutions
      • Siloam Biosciences
      • Singlera Genomics
      • Sintact Medical Systems
      • Sividon Diagnostics
      • SkinCure Oncology
      • SkylineDX
      • Skyline Medical
      • Skyline Urology
      • Small Business Innovation Research
      • Smilow Cancer Hospital at Yale-New Haven (SCH)
      • Sofie Biosciences
      • SolaranRx
      • Sonic Healthcare
      • Sophia Genetics
      • Sorgente
      • Soricimed Biopharma
      • Sorrento Therapeutics
      • SouthGenetics
      • Southwest Gynecological Pathology Lab
      • Spectrum Health
      • Spectrum Pharmaceuticals
      • SpePharm
      • Sphingotec
      • Sprint Biosciences
      • SRI International
      • SST Group
      • Stanford Health Care
      • Stanford University
      • Stanford University School of Medicine
      • Strata Oncology
      • Stratose
      • Streck Laboratories
      • Stroke Detection Plus
      • Sunnybrook Health Sciences Centre
      • SuperSonic Imagine
      • Surrey Cancer Research Institute
      • Susan G. Komen for the Cure
      • Swift Biosciences
      • Swiss Institute of Allergy and Asthma Research
      • SWOG Cancer Research
      • Syapse
      • SYGNIS Pharma
      • Synaptive Medical
      • Sysmex
      • Sysmex Inostics
      • TaiRx
      • TaiRx US
      • Take2
      • Takeda Pharmaceutical
      • Targos
      • Tasly Pharmaceuticals
      • Technology Transfer Accelerator
      • TeleMammography Specialists
      • Telik
      • Telix Pharmaceuticals
      • Temple University
      • Tempus
      • Teneovita Medical
      • Tesaro
      • TestAnalytika
      • Teva Pharmaceutical Industries
      • Texas A&M University
      • Theraclion
      • Theradiag
      • Theragnostics
      • Theranostics Health
      • Thermo Fisher Scientific
      • The Binding Site
      • The Christie
      • The Fleury Group
      • The Haematological Malignancy Research Network
      • The Parker Institute For Cancer Immunotherapy
      • Thomas Jefferson University
      • Three Rivers Provider Network
      • Threshold Pharmaceuticals
      • Tiziana Life Sciences
      • TNK Therapeutics
      • Tocagen
      • Todos Medical
      • Tokai Pharmaceuticals
      • Tolero Pharmaceuticals
      • Toronto Innovation Acceleration Partners
      • TP Therapeutics
      • TRACON Pharmaceuticals
      • Transgenomic
      • Translational Drug Development
      • Translational Genomics Research Institute
      • TrovaGene
      • TTFactor
      • Tuberous Sclerosis Alliance (TS Alliance)
      • Tulane University
      • Turgut Ilaclari
      • Turku PET Center
      • UBiome
      • Unified Women's Clinical Research
      • Unilabs
      • UnitedHealthcare
      • United Imaging Healthcare
      • United States Military Cancer Institute
      • University Ann & Robert H. Lurie Children's Hospital
      • University City Science Center
      • University College London
      • University Health Network
      • University Hospital of Leuven
      • University Medical Center Hamburg-Eppendorf
      • University of Arizona
      • University of Arkansas
      • University of California, San Diego
      • University of California
      • University of California Irvine
      • University of California Los Angeles
      • University of California San Francisco
      • University of Colorado
      • University of Colorado Denver
      • University of Florida
      • University of Greifswald
      • University of Heidelberg
      • University of Leeds
      • University of Louisville
      • University of Massachusetts Medical School
      • University of Melbourne
      • University of Michigan
      • University of Minnesota
      • University of Oxford
      • University of Pennsylvania
      • University of Rostock
      • University of Sunderland
      • University of Surrey
      • University of Texas Health SCience Center at San Antonio
      • University of Tokyo
      • University of Torino
      • University of Toronto
      • University of Washington
      • UPMC
      • Uppsala University Hospital
      • USC Norris Comprehensive Cancer Center
      • US Oncology
      • US Oncology Research
      • US Radiology Specialists
      • Vanderbilt-Ingram Cancer Center
      • Vantage Health
      • Varian Medical Systems
      • Vect-Horus
      • Vector Oncology
      • Velocity Medical Solutions
      • Ventana Medical Systems
      • Veracyte
      • Verisante Technology
      • Vermillion
      • Viatar CTC Solutions
      • ViewRay
      • Vigilant Biosciences
      • Virginia Tech Intellectual Properties
      • Vitatex
      • Vizient
      • VolitionRX
      • Volpara Solutions
      • VuCOMP
      • Vyriad
      • WaferGen Biosystems
      • Wallace H. Coulter Foundation
      • Weill Cornell Medical College
      • Wellcome Trust Sanger Institute
      • Worldwide Innovative Network (WIN) in personalized cancer medicine Consortium
      • Wuhan Kindstar Diagnostics
      • WuXi NextCODE Genomics
      • WuXi PharmaTech
      • Xiamen Encheng Group
      • Xylonix
      • Yale School of Medicine
      • Ymir Genomics
      • Zebra Medical Vision
      • Zenalux Biomedical
      • Zenon Biosystem
      • Zenosense
      • Zero Cancer Reserach Fund
      • ZoBio
      • Zomedica
    • Cancer Diagnostics deals by stage of development
      • Discovery
      • Preclinical
      • Phase I
      • Phase II
      • Phase III
      • Regulatory
      • Marketed
    • Cancer Diagnostics deals by deal type
      • Asset purchase
      • Bigpharma outlicensing
      • Co-development
      • Collaborative R&D
      • Co-market
      • Contract Services
      • Co-promotion
      • CRADA
      • Development
      • Distribution
      • Evaluation
      • Grant
      • Joint venture
      • Licensing
      • Manufacturing
      • Manufacturing - OEM
      • Marketing
      • Material transfer
      • Option
      • Promotion
      • Research
      • Spin out
      • Sub-license
      • Supply
      • Termination
    • Cancer Diagnostics deals by therapy area
      • Oncology
      • Adenocarcinoma
      • Basal cell carcinoma
      • Bile duct cancer
      • Bladder cancer
      • Brain cancer
      • Glioblastoma
      • Breast cancer
      • Cervical cancer
      • Colorectal cancer
      • Endometrial
      • Esophageal cancer
      • Gastric cancer
      • Head and neck cancer
      • Kidney cancer
      • Leukemia
      • Acute lymphoblastic leukemia
      • Acute myelogenous leukemia
      • Chronic lymphocytic leukemia
      • Chronic myelogenous leukemia
      • Liver cancer
      • Lung cancer
      • Non small cell lung cancer
      • Small cell lung cancer
      • Lymphoma
      • Hodgkin's lymphoma
      • Non Hodgkin's lymphoma
      • Melanoma
      • Mesothelioma
      • Metastases
      • Multiple myeloma
      • Ovarian cancer
      • Pancreatic cancer
      • Prostate cancer
      • Renal cell carcinoma
      • Sarcoma
      • Solid tumors
      • Radiotherapy
      • Thyroid cancer
    • Deal type definitions
  • About Wildwood Ventures
    • Current Partnering
    • Current Agreements
    • Recent report titles from Current Partnering

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook